Over the last several decades, there has been continued interest and focus on new therapeutic modalities for the regulation of protein expression at the RNA, and even DNA level. The purification of oligonucleotides (ONs) can be particularly challenging with the high similarity of API and impurities.

Agilent recognizes the unique challenges for each oligonucleotide API, offering a range of chemistries, pore size, and dimensions to meet your needs.